HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Hypothalamic amenorrhea — Clinical Guidelines

Overview

Hypothalamic amenorrhea is characterized by the absence of menstruation due to dysfunction in the hypothalamic-pituitary-ovarian axis, often triggered by factors such as stress, excessive exercise, and nutritional deficiencies 2.

Diagnosis

Clinical History: Detailed assessment of exercise intensity, dietary habits, stress levels, and any underlying medical conditions 2 3 6.

Physical Examination: Evaluation of body composition, including body weight and fat percentage 8 11.

Laboratory Tests:

- Serum LH, FSH, estradiol, prolactin, and thyroid function tests 7 10. - Insulin sensitivity tests and 24-hour hormonal profiles 6.

Imaging: Not typically required unless organic causes are suspected 2.

Management

First-Line Treatments:

- Nutritional Counseling: Addressing caloric and macronutrient deficiencies 2 6. - Reduction in Exercise Intensity: Gradual decrease in training volume and intensity 2 3 8. - Hormonal Therapy: Consideration of low-dose estrogen or combined oral contraceptives to restore cyclicity and bone health 2 4 9.

Adjunctive Treatments:

- Psychological Support: Stress management and counseling to address psychological triggers 2. - Calcium and Vitamin D Supplementation: To mitigate bone density loss 2.

Special Populations

Athletes: Tailored management focusing on balancing training load with nutritional intake and hormonal support 3 8 11.

Pediatrics: Special attention to growth and development, with cautious use of hormonal interventions 2.

Key Recommendations

Comprehensive Evaluation: Include detailed history, physical examination, and laboratory assessment of hormonal profiles and nutritional status (Evidence: Strong 2 6 7).

Nutritional and Exercise Modifications: Implement dietary counseling and reduce exercise intensity to restore normal menstrual function (Evidence: Strong 2 3 6 8).

Hormonal Therapy Consideration: Use low-dose estrogen or combined oral contraceptives to manage amenorrhea and prevent bone loss, particularly in athletes and adolescents (Evidence: Moderate 2 4 9).

Psychological Support: Provide counseling to address stress and psychological factors contributing to amenorrhea (Evidence: Moderate 2).

Monitor Bone Health: Supplement with calcium and vitamin D to prevent osteoporosis (Evidence: Moderate 2).

References

1 Al-Taiar A, Al-Sabah R, Shaban L, Sharaf Alddin R, Durgampudi PK, Galadima H. Is age of menarche directly related to vitamin D levels?. American journal of human biology : the official journal of the Human Biology Council 2022. link 2 Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra M et al.. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism 2017. link 3 Carlson JL, Curtis M, Halpern-Felsher B. Clinician practices for the management of amenorrhea in the adolescent and young adult athlete. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2007. link 4 Rickenlund A, Carlström K, Ekblom B, Brismar TB, Von Schoultz B, Hirschberg AL. Effects of oral contraceptives on body composition and physical performance in female athletes. The Journal of clinical endocrinology and metabolism 2004. link 5 Chompootaweep S, Tankeyoon M, Poomsuwan P, Yamarat K, Dusitsin N. Age at menarche in Thai girls. Annals of human biology 1997. link 6 Laughlin GA, Yen SS. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. The Journal of clinical endocrinology and metabolism 1996. link 7 Berga SL, Mortola JF, Girton L, Suh B, Laughlin G, Pham P et al.. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. The Journal of clinical endocrinology and metabolism 1989. link 8 Sinning WE, Little KD. Body composition and menstrual function in athletes. Sports medicine (Auckland, N.Z.) 1987. link 9 Prior JC, Vigna Y. Gonadal steroids in athletic women contraception, complications and performance. Sports medicine (Auckland, N.Z.) 1985. link 10 Russell JB, Mitchell D, Musey PI, Collins DC. The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstetrics and gynecology 1984. link 11 Carlberg KA, Buckman MT, Peake GT, Riedesel ML. Body composition of oligo/amenorrheic athletes. Medicine and science in sports and exercise 1983. link 12 Mathur DN, Toriola AL. Age at menarche in Nigerian athletes. British journal of sports medicine 1982. link 13 Weisberg E. Fertility after discontinuation of oral contraceptives. Clinical reproduction and fertility 1982. link 14 Wakat DK, Sweeney KA, Rogol AD. Reproductive system function in women cross-country runners. Medicine and science in sports and exercise 1982. link 15 Frisch RE, Gotz-Welbergen AV, McArthur JW, Albright T, Witschi J, Bullen B et al.. Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. JAMA 1981. link 16 McArthur JW, Bullen BA, Beitins IZ, Pagano M, Badger TM, Klibanski A. Hypothalamic amenorrhea in runners of normal body composition. Endocrine research communications 1980. link

Hypothalamic amenorrhea